NO961775L - Fremgangsmåte og sammensetning for behandling av pasienter med dekompensert leversykdom - Google Patents
Fremgangsmåte og sammensetning for behandling av pasienter med dekompensert leversykdomInfo
- Publication number
- NO961775L NO961775L NO961775A NO961775A NO961775L NO 961775 L NO961775 L NO 961775L NO 961775 A NO961775 A NO 961775A NO 961775 A NO961775 A NO 961775A NO 961775 L NO961775 L NO 961775L
- Authority
- NO
- Norway
- Prior art keywords
- patients
- treatment
- composition
- liver disease
- decompensated liver
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2292—Thymosin; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1993/010619 WO1995012405A1 (en) | 1993-11-05 | 1993-11-05 | Method and composition for treatment of patients having decompensated liver disease |
Publications (2)
Publication Number | Publication Date |
---|---|
NO961775L true NO961775L (no) | 1996-05-02 |
NO961775D0 NO961775D0 (no) | 1996-05-02 |
Family
ID=22237139
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO961775A NO961775D0 (no) | 1993-11-05 | 1996-05-02 | Fremgangsmåte og sammensetning for behandling av pasienter med dekompensert leversykdom |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0731710B1 (no) |
KR (1) | KR100298859B1 (no) |
CA (1) | CA2175337C (no) |
DE (1) | DE69332982T2 (no) |
DK (1) | DK0731710T3 (no) |
ES (1) | ES2194860T3 (no) |
HK (1) | HK1021685A1 (no) |
MX (1) | MXPA94003453A (no) |
MY (1) | MY111342A (no) |
NO (1) | NO961775D0 (no) |
PT (1) | PT731710E (no) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW224053B (no) * | 1991-09-13 | 1994-05-21 | Paul B Chretien | |
WO1995011688A1 (en) * | 1992-02-06 | 1995-05-04 | Sciclone Pharmaceuticals | Method for treating hepatitis b carriers with minimal disease |
AU4671193A (en) * | 1992-07-13 | 1994-01-31 | Kenneth E. Sherman | Composition and method of treating hepatitis b |
-
1993
- 1993-11-05 CA CA002175337A patent/CA2175337C/en not_active Expired - Fee Related
- 1993-11-05 DK DK94901265T patent/DK0731710T3/da active
- 1993-11-05 MX MXPA94003453A patent/MXPA94003453A/es not_active IP Right Cessation
- 1993-11-05 EP EP94901265A patent/EP0731710B1/en not_active Expired - Lifetime
- 1993-11-05 KR KR1019960702942A patent/KR100298859B1/ko not_active IP Right Cessation
- 1993-11-05 ES ES94901265T patent/ES2194860T3/es not_active Expired - Lifetime
- 1993-11-05 DE DE69332982T patent/DE69332982T2/de not_active Expired - Fee Related
- 1993-11-05 PT PT94901265T patent/PT731710E/pt unknown
-
1994
- 1994-05-09 MY MYPI94001152A patent/MY111342A/en unknown
-
1996
- 1996-05-02 NO NO961775A patent/NO961775D0/no not_active Application Discontinuation
-
1998
- 1998-12-19 HK HK98114128A patent/HK1021685A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2175337C (en) | 2000-06-20 |
DK0731710T3 (da) | 2003-06-16 |
KR100298859B1 (ko) | 2001-10-22 |
KR960706352A (ko) | 1996-12-09 |
DE69332982T2 (de) | 2004-09-09 |
MXPA94003453A (es) | 2004-08-16 |
EP0731710B1 (en) | 2003-05-14 |
ES2194860T3 (es) | 2003-12-01 |
CA2175337A1 (en) | 1995-05-11 |
EP0731710A1 (en) | 1996-09-18 |
EP0731710A4 (en) | 1999-12-22 |
HK1021685A1 (en) | 2000-06-23 |
PT731710E (pt) | 2003-09-30 |
MY111342A (en) | 1999-11-30 |
NO961775D0 (no) | 1996-05-02 |
DE69332982D1 (de) | 2003-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO894296L (no) | Fremgangsmaate for behandling av leddgikt og betennelsessykdommer. | |
BR9407799A (pt) | Composição de matéria método de tratamento e composição farmaceutica | |
KR100344712B1 (ko) | 알러지성및염증성질환의치료에유용한화합물 | |
FI944549A0 (fi) | Allergisten ja tulehdussairauksien hoidossa käyttökelpoiset yhdisteet | |
FI954718A (fi) | Heterosykliset johdannaiset iskeemian ja vastaavien sairauksien hoitamiseksi | |
NO992641D0 (no) | Blandinger og fremgangsmÕter for behandling eller forhindring av betennelsessykdommer | |
NO914315D0 (no) | Fremgangsmaate og sammensetning for surgjoering av underjordiske formasjoner | |
FI971969A0 (fi) | Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä | |
NO972972D0 (no) | Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse | |
EP0717592A4 (en) | METHOD AND COMPOSITION FOR TREATING THE APATHIE DEMOTIVATION SYNDROME | |
NO953254D0 (no) | Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter | |
KR880700673A (ko) | 골손상 치료용방법 및 조성물 | |
NO940027L (no) | Fremgangsmaate for fremstilling av derivater av B-fenylisorerin og derivatenes anvendelse | |
NO961226L (no) | Blandinger for forebyggelse og behandling av viralinduserte tumorer | |
NO171798C (no) | Fremgangsmaate for behandling av sinkholdige biprodukter og avfallsmaterialer | |
AU1104392A (en) | Method for the treatment of hepatic failure and disease | |
NO973193D0 (no) | Kollagen-baserte metoder og formuleringer for behandling av immune system-medierte sykdommer | |
AU4787593A (en) | Heterocyclic derivatives useful in the treatment of cardiovascular diseases | |
GB9010058D0 (en) | Method and composition for the treatment of cancer | |
NO961775D0 (no) | Fremgangsmåte og sammensetning for behandling av pasienter med dekompensert leversykdom | |
NO942531D0 (no) | Fremgangsmåte for fremstilling av 3-acylöstratriener og acylbenzener | |
DK0670721T3 (da) | Lægemiddel til behandling og forebyggelse af knogle- og ledsygdomme | |
NO953002D0 (no) | Anvendelse av eliprodil og enantiomerer derav for fremstilling av medisinske preparater | |
GB2279567B (en) | Compositions for the treatment of inflammatory proliferative skin disease and their use | |
UA10998C2 (uk) | Спосіб поліфакторhої лікувальhої дії та ковдра для поліфакторhої лікувальhої дії |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |